These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8834055

  • 1. Human growth hormone treatment in prepubertal children with achondroplasia.
    Weber G, Prinster C, Meneghel M, Russo F, Mora S, Puzzovio M, Del Maschio M, Chiumello G.
    Am J Med Genet; 1996 Feb 02; 61(4):396-400. PubMed ID: 8834055
    [Abstract] [Full Text] [Related]

  • 2. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 3. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May 03; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct 03; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 5. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E, Cassorla F, Tiulpakov AN, Mericq MV, Avila A, Pescovitz OH, Svensson J, Cerchio K, Krupa D, Gertz BJ, Murphy G.
    Clin Pharmacol Ther; 2001 Jul 03; 70(1):91-8. PubMed ID: 11452249
    [Abstract] [Full Text] [Related]

  • 6. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R, Jakubowicz S.
    J Pediatr; 2002 Nov 03; 141(5):606-10. PubMed ID: 12410186
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone therapy in achondroplasia.
    Horton WA, Hecht JT, Hood OJ, Marshall RN, Moore WV, Hollowell JG.
    Am J Med Genet; 1992 Mar 01; 42(5):667-70. PubMed ID: 1632435
    [Abstract] [Full Text] [Related]

  • 8. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F.
    Horm Metab Res; 2005 Dec 01; 37(12):751-6. PubMed ID: 16372229
    [Abstract] [Full Text] [Related]

  • 9. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G, Trivin C, Brauner R, Souberbielle JC.
    Growth Horm IGF Res; 2007 Jun 01; 17(3):194-200. PubMed ID: 17321775
    [Abstract] [Full Text] [Related]

  • 10. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Jun 01; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 11. Effect of nutrition on growth in short stature before and during growth-hormone therapy.
    Zadik Z, Sinai T, Zung A, Reifen R.
    Pediatrics; 2005 Jul 01; 116(1):68-72. PubMed ID: 15995033
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of growth hormone therapy for patients with skeletal dysplasia.
    Kanazawa H, Tanaka H, Inoue M, Yamanaka Y, Namba N, Seino Y.
    J Bone Miner Metab; 2003 Jul 01; 21(5):307-10. PubMed ID: 12928832
    [Abstract] [Full Text] [Related]

  • 13. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
    Danne T, Grüters A, Schnabel K, Burger W, L'Allemand D, Enders I, Helge H, Weber B.
    Pediatr Res; 1988 Feb 01; 23(2):167-71. PubMed ID: 3353159
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
    Butenandt O, Lang G.
    J Pediatr Endocrinol Metab; 1997 Feb 01; 10(3):275-82. PubMed ID: 9388818
    [Abstract] [Full Text] [Related]

  • 15. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec 01; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 16. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
    Huseman CA, Colombo JL, Brooks MA, Smay JR, Greger NG, Sammut PH, Bier DM.
    Pediatr Pulmonol; 1996 Aug 01; 22(2):90-5. PubMed ID: 8875581
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone therapy in achondroplasia.
    Seino Y, Yamanaka Y, Shinohara M, Ikegami S, Koike M, Miyazawa M, Inoue M, Moriwake T, Tanaka H.
    Horm Res; 2000 Aug 01; 53 Suppl 3():53-6. PubMed ID: 10971105
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone therapy in achondroplasia.
    Nishi Y, Kajiyama M, Miyagawa S, Fujiwara M, Hamamoto K.
    Acta Endocrinol (Copenh); 1993 May 01; 128(5):394-6. PubMed ID: 8317186
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) treatment in achondroplasia.
    Yamate T, Kanzaki S, Tanaka H, Kubo T, Moriwake T, Inoue M, Seino Y.
    J Pediatr Endocrinol; 1993 May 01; 6(1):45-52. PubMed ID: 8374688
    [Abstract] [Full Text] [Related]

  • 20. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia.
    Shohat M, Tick D, Barakat S, Bu X, Melmed S, Rimoin DL.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):4033-7. PubMed ID: 8923856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.